Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: A randomised, investigator-blinded, controlled, phase III study throughout Europe

Journal of the European Academy of Dermatology and Venereology

Volumn 29, Issue 12, 2015, Pages 2342-2348

  Lacour, J P ^a   Ulrich, C ^b   Gilaberte, Y ^c   Von Felbert, V ^d   Basset Seguin, N ^e   Dreno, B ^f   Girard, C ^g   Redondo, P ^h   Serra Guillen, C ⁱ   Synnerstad, I ^j   Tarstedt, M ^k   Tsianakas, A ^l   Venema, A W ^m   Kelleners Smeets, N ⁿ   Adamski, H ^o   Perez Garcia, B ^p   Gerritsen, M J ^q   Leclerc, S ^r   Kerrouche, N ^r   Szeimies, R M ^s  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HOSPITAL SAN JORGE   (Spain)

^d UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^e SAINT LOUIS HOSPITAL   (France)

^f HÔTEL DIEU   (France)

^g HÔPITAL SAINT ELOI   (France)

^h UNIVERSITY CLINIC OF NAVARRA   (Spain)

ⁱ INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^j Hudmottagningen   (Sweden)

^k Karlskoga Hospital   (Sweden)

^l UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^m Wilhelmina Ziekenhuis   (Netherlands)

ⁿ MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^o PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^p HOSPITAL RAMÓN Y CAJAL   (Spain)

^q RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^r Galderma R and D   (France)

^s Klinikum Vest GmbH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT; SKIN CREAM;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREAM; DAYLIGHT PHOTODYNAMIC THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; EUROPE; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PAIN ASSESSMENT; PHASE 3 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCABIES; SKIN BURNING SENSATION; TREATMENT RESPONSE; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; COMPARATIVE STUDY; FACIAL DERMATOSES; KERATOSIS, ACTINIC; MIDDLE AGED; PAIN; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PROCEDURES; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX; SINGLE BLIND PROCEDURE; SUNLIGHT; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; EUROPE; FACIAL DERMATOSES; FEMALE; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PAIN; PATIENT SATISFACTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SCALP DERMATOSES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; SKIN CREAM; SUNLIGHT; TREATMENT OUTCOME;

EID: 84952865984     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.13228     Document Type: Article

References (26)

1. Memon AA, Tomenson JA, Bothwell J, Friedmann PS,. Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 2000; 142: 1154-1159.
2. Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T,. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133: 1971-1978.
3. Holmes C, Foley P, Freeman M, Chong AH,. Solar keratosis: epidemiology, pathogenesis, presentation and treatment. Australas J Dermatol 2007; 48: 67-74.
4. Wan MT, Lin JY,. Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol 2014; 7: 145-163.
5. Stockfleth E,. Actinic Keratosis and Field Cancerization: New Insights. Medscape 2012. [WWW document]. URL http://www.medscape.org/viewarticle/774743 (last accessed: 10 October 2014).
6. Stockfleth E, Peris K, Guillen C, et al,. Physician perceptions and experience of current treatment in actinic keratosis. J Eur Acad Dermatol Venereol 2015; 29: 298-306.
7. Spencer JM, Hazan C, Hsiung SH, Robins P,. Therapeutic decision making in the therapy of actinic keratoses. J Drugs Dermatol 2005; 4: 296-301.
8. Vatve M, Ortonne JP, Birch-Machin MA, Gupta G,. Management of field change in actinic keratosis. Br J Dermatol 2007; 157 (Suppl 2): 21-24.
9. Stockfleth E, Ferrandiz C, Grob JJ, et al,. Development of a treatment algorithm for actinic keratoses: a European Consensus. Eur J Dermatol 2008; 18: 651-659.
10. McIntyre WJ, Downs MR, Bedwell SA,. Treatment options for actinic keratoses. Am Fam Physician 2007; 76: 667-671.
11. Morton CA, Szeimies RM, Sidoroff A, Braathen LR,. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications-actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 2013; 27: 536-544.
12. Sidoroff A, Thaler P,. Taking treatment decisions in non-melanoma skin cancer-the place for topical photodynamic therapy (PDT). Photodiagnosis Photodyn Ther 2010; 7: 24-32.
13. Lehmann P,. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007; 156: 793-801.
14. de Berker D, McGregor JM, Hughest BR,. Guidelines for the management of actinic keratoses. Br J Dermatol 2007; 156: 222-230.
15. Braathen LR, Szeimies RM, Basset-Seguin N, et al,. International Society for Photodynamic Therapy in Dermatology. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol 2007; 56: 125-143.
16. ™ expert clinicians. J Eur Acad Dermatol Venereol 2014; 28: 1141-1149.
17. Patel G, Armstrong AW, Eisen DB,. Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis. JAMA Dermatol 2014; 150: 1281-1288.
18. Kennedy JC, Pottier RH,. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-292.
19. Wiegell S, Hædersdal M, Philipsen P, et al,. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-746.
20. Rubel DM, Spelman L, Murrell DF, et al,. Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial. Br J Dermatol 2014; 171: 1164-1171.
21. Fai D, Romano I, Fai C, Cassano N, Vena GA,. Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in southern Italy. G Ital Dermatol Venereol 2014; Oct 3. [Epub ahead of print].
22. Olsen EA, Abernethy L, Kulp-Shorten C, et al,. A double-blind vehicle controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. J Am Acad Dermatol 1991; 24: 738-743.
23. Javor S, Chimenti S, Patrizi A, et al,. Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does gender have a role? G Ital Dermatol Venereol 2014; 149: 199-204.
24. Ceilley RI, Jorizzo JL,. Current issues in the management of actinic keratosis. J Am Acad Dermatol 2013; 68 (1 Suppl 1): S28-S38.
25. Bouwes Bavinck JN, Euvrard S, Naldi L, et al,. Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy. J Invest Dermatol 2007; 127: 1647-1656.
26. Togsverd-Bo K, Lei U, Erlendsson AM, et al,. Combination of ablative fractional laser and daylight mediated photodynamic therapy for actinic keratosis in organ transplant recipients - A randomized controlled trial. Br J Dermatol 2015; 172: 467-474.